These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 19447317)
1. Understanding the genetic determinants of pain and pain management. Miaskowski C Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S1-7. PubMed ID: 19447317 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics in pain management: the clinical need. Webster LR Clin Lab Med; 2008 Dec; 28(4):569-79. PubMed ID: 19059063 [TBL] [Abstract][Full Text] [Related]
3. Can heterogeneity of chronic sickle-cell disease pain be explained by genomics? A literature review. Adegbola MA Biol Res Nurs; 2009 Jul; 11(1):81-97. PubMed ID: 19487302 [TBL] [Abstract][Full Text] [Related]
4. Current evidence for a genetic modulation of the response to analgesics. Lötsch J; Geisslinger G Pain; 2006 Mar; 121(1-2):1-5. PubMed ID: 16472919 [No Abstract] [Full Text] [Related]
5. Genetic factors in pain and its treatment. Stamer UM; Stüber F Curr Opin Anaesthesiol; 2007 Oct; 20(5):478-84. PubMed ID: 17873601 [TBL] [Abstract][Full Text] [Related]
6. [Genetic polymorphisms and human sensitivity to pain and opioids]. Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431 [TBL] [Abstract][Full Text] [Related]
8. The use of risk-management approaches to protect patients with cancer-related pain and their healthcare providers. Miaskowski C Oncol Nurs Forum; 2008 Nov; 35 Suppl():20-4. PubMed ID: 18980936 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics in palliative care. Kleine-Brueggeney M; Musshoff F; Stuber F; Stamer UM Forensic Sci Int; 2010 Dec; 203(1-3):63-70. PubMed ID: 20709477 [TBL] [Abstract][Full Text] [Related]
11. [Genetic variation-- important for the clinical effect of opioids?]. Klepstad P; Dale O; Borchgrevink PC; Kaasa S; Skorpen F Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2655-8. PubMed ID: 16215614 [TBL] [Abstract][Full Text] [Related]
12. [Individual differences in analgesic effects of narcotics]. Ide S; Kasai S; Ikeda K Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):43-8. PubMed ID: 18411709 [TBL] [Abstract][Full Text] [Related]
13. Effect of genetic factors on opioid action. Kosarac B; Fox AA; Collard CD Curr Opin Anaesthesiol; 2009 Aug; 22(4):476-82. PubMed ID: 19502975 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in the pharmacogenomics of pain and headache. Montagna P Neurol Sci; 2007 May; 28 Suppl 2():S208-12. PubMed ID: 17508172 [TBL] [Abstract][Full Text] [Related]
15. The application of genomic and molecular data in the treatment of chronic cancer pain. Turabi A; Plunkett AR J Surg Oncol; 2012 Apr; 105(5):494-501. PubMed ID: 22441902 [TBL] [Abstract][Full Text] [Related]
16. Clinical approaches to special issues related to opioid therapy. Fine PG Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S20-8. PubMed ID: 19447318 [TBL] [Abstract][Full Text] [Related]
17. [Genetic polymorphisms and opioid therapies]. Landau R Presse Med; 2008 Oct; 37(10):1415-22. PubMed ID: 18440763 [TBL] [Abstract][Full Text] [Related]
18. Cancer genetics nursing: impact of the double helix. Greco KE Oncol Nurs Forum; 2000 Oct; 27(9 Suppl):29-36. PubMed ID: 11058981 [TBL] [Abstract][Full Text] [Related]